Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,725 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,608 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00112294 | Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 755 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00762034 | A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 3 | 939 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 21, 2015 | clinicaltrials |
| NCT00883779 | A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 3 | 451 | Hoffmann-La RocheINDUSTRY | 7 | Dec 14, 2015 | clinicaltrials |
| NCT00409188 | Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)(START) | completed | Phase 3 | 1,513 | EMD SeronoINDUSTRY | 33 | Nov 20, 2015 | clinicaltrials |
| NCT00002550 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 3 | 429 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00373425 | A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors(RADIANT) | completed | Phase 3 | 1,252 | OSI PharmaceuticalsINDUSTRY | 19 | Sep 17, 2015 | clinicaltrials |
| NCT00210080 | A Study to Diagnose Lung Cancer by Sputum Cytology (01-312) | completed | Phase 3 | 700 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 4, 2015 | clinicaltrials |
| NCT01183858 | A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) | completed | Phase 3 | 315 | Hoffmann-La RocheINDUSTRY | 9 | Aug 19, 2015 | clinicaltrials |
| NCT01017874 | A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer | completed | Phase 3 | 236 | Eli Lilly and CompanyINDUSTRY | 5 | Jul 8, 2015 | clinicaltrials |
| NCT02486354 | Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy | completed | Phase 3 | 128 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 1, 2015 | clinicaltrials |
| NCT00326378 | Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer | completed | Phase 3 | 434 | Samsung Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00676507 | Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy(STOP) | completed | Phase 3 | 532 | NovaRx CorporationINDUSTRY | 8 | May 8, 2015 | clinicaltrials |
| NCT00172042 | A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 437 | Novartis PharmaceuticalsINDUSTRY | 15 | May 4, 2015 | clinicaltrials |
| NCT00420160 | Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women? | completed | Phase 2 / Phase 3 | 59 | The Miriam HospitalOTHER | 1 | Apr 14, 2015 | clinicaltrials |
| NCT01282437 | Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC(NVALT11) | completed | Phase 3 | 315 | Maastricht Radiation OncologyOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01134861 | Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 610 | Radiation Therapy Oncology GroupNETWORK | 0 | Mar 27, 2015 | clinicaltrials |
| NCT01342965 | A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations | completed | Phase 3 | 217 | Hoffmann-La RocheINDUSTRY | 3 | Feb 24, 2015 | clinicaltrials |
| NCT00556322 | A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 27 | Feb 23, 2015 | clinicaltrials |
| NCT00658580 | Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer | completed | Phase 3 | 361 | European Lung Cancer Working PartyOTHER | 4 | Feb 12, 2015 | clinicaltrials |
| NCT00556712 | A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 889 | Hoffmann-La RocheINDUSTRY | 28 | Feb 11, 2015 | clinicaltrials |
| NCT00718315 | A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. | completed | Phase 3 | 201 | Hoffmann-La RocheINDUSTRY | 1 | Jan 15, 2015 | clinicaltrials |
| NCT00049543 | Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | completed | Phase 3 | 503 | National Cancer Institute (NCI)NIH | 1 | Jan 1, 2015 | clinicaltrials |
| NCT01955824 | A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy | completed | Phase 2 / Phase 3 | 500 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Dec 30, 2014 | clinicaltrials |
| NCT00102804 | Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 663 | Eli Lilly and CompanyINDUSTRY | 20 | Dec 29, 2014 | clinicaltrials |
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer(TOPICAL) | completed | Phase 3 | 670 | University College, LondonOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00309972 | Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery(SOCCAR) | completed | Phase 3 | 130 | University College, LondonOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00433498 | Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer | completed | Phase 3 | 846 | University College, LondonOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT01782053 | Communicating Smoking Risks Through Graphic Warning Labels | completed | Phase 3 | 245 | University of PennsylvaniaOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00003313 | Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | completed | Phase 3 | 243 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 21, 2014 | clinicaltrials |
| NCT00874419 | Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation(ML20981) | completed | Phase 3 | 165 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT00321334 | Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC | completed | Phase 3 | 410 | Chinese Society of Lung CancerOTHER | 1 | Aug 6, 2014 | clinicaltrials |
| NCT00660504 | Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer | completed | Phase 3 | 300 | Marubeni Pharmaceuticals (Suzhou) Co., Ltd.INDUSTRY | 1 | Jul 18, 2014 | clinicaltrials |
| NCT00415818 | Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 148 | TransgeneINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT00499109 | Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | completed | Phase 3 | 275 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 3 | Jul 9, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT01281787 | PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer(PRESAGE) | completed | Phase 3 | 320 | European Institute of OncologyOTHER | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00003869 | Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer | completed | Phase 3 | 186 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00047385 | National Lung Screening Trial (NLST) Screening(NLST) | completed | Phase 3 | 53,454 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00820755 | Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)(NEXT) | completed | Phase 3 | 583 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 5, 2014 | clinicaltrials |
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | completed | Phase 3 | — | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 28 | Mar 13, 2014 | clinicaltrials |
| NCT00091663 | A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 5,000 | Genentech, Inc.INDUSTRY | 1 | Mar 4, 2014 | clinicaltrials |
| NCT01028417 | Study to See if Microcoil Insertion Reduces the Rate of Open Thoracotomy for Removal of Lung Nodules | completed | Phase 3 | 60 | University of British ColumbiaOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01038661 | Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy(TFINE) | completed | Phase 3 | 375 | SanofiINDUSTRY | 1 | Feb 28, 2014 | clinicaltrials |
| NCT01040780 | Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients(ICOGEN) | completed | Phase 3 | 399 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | completed | Phase 3 | 472 | GlaxoSmithKlineINDUSTRY | 6 | Jan 20, 2014 | clinicaltrials |
| NCT00003917 | Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 3 | 4 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00041015 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 4 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00002822 | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | completed | Phase 3 | 400 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003364 | Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | completed | Phase 3 | 398 | London Lung Cancer GroupOTHER | 1 | Dec 19, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Dec 24, 2015source: clinicaltrials